{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:25Z","timestamp":1792979905096,"version":"4.5.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neutropenia during valganciclovir (VGCV) prophylaxis for cytomegalovirus infection in pediatric solid organ transplant (pSOT) recipients is common, but it is uncertain if this toxicity is exposure\u2010dependent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To compare ganciclovir (GCV) exposures in children treated with VGCV with and without neutropenia, we performed a retrospective matched case\u2010control study among pSOT prescribed VGCV, dosed based on body surface area. Cases were defined as an absolute neutrophil count (ANC)\u00a0&lt;\u00a01000\/\u00b5L. Controls without neutropenia were matched by age (+\/\u22121 year), transplanted organ, and duration of VGCV prophylaxis. We used a published population pharmacokinetic model to inform predictions of GCV concentrations using Pmetrics, accounting for each subject's time\u2010dependent variables (age, weight, creatinine clearance). We then calculated 24\u2010h, 7\u2010day, and cumulative area under the curve (AUC) in each subject and used conditional logistic regression to compare GCV exposures among cases and controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 164 pSOT recipients prescribed VGCV, we identified 35 case\u2010control matches. There were no statistically significant differences in the 24\u2010h (odds ratio [OR] 0.990, 95% confidence interval [CI] 0.964\u20131.018), 7\u2010day (OR 1.000, 95% CI 0.996\u20131.004), or cumulative AUCs (OR 1.00, 95% CI 0.9996\u20131.00) among all cases and controls. AUC metrics by SOT type also showed no statistically significant differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Predicted GCV exposures were similar among pSOT recipients with and without neutropenia, suggesting that differences in dosing and pharmacokinetics covariates did not drive toxicity in our population. Measurement of GCV concentrations may discern whether toxicity relates to exposures\/concentrations or intrinsic factors (i.e., genetics) in the pSOT population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tid.70146","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:20:10Z","timestamp":1765293610000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Matched Case\u2010Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-2019","authenticated-orcid":false,"given":"Mai\u2010Uyen T.","family":"Nguyen","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases Children's Hospital of Philadelphia  Philadelphia Pennsylvania USA"},{"name":"Department of Pharmacology Physiology &amp; Cancer Biology Thomas Jefferson University  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-8276","authenticated-orcid":false,"given":"Michael N.","family":"Neely","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Children's Hospital of Los Angeles  Los Angeles California USA"},{"name":"Department of Pediatrics Keck School of Medicine, University of Southern California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-1769","authenticated-orcid":false,"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Biosciences School of Pharmacy University of Oslo  Oslo Norway"},{"name":"Department of Transplantation Medicine Oslo University Hospital, Rikshospitalet  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9226-5529","authenticated-orcid":false,"given":"Craig L. K.","family":"Boge","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Children's Hospital of Philadelphia  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5015-8146","authenticated-orcid":false,"given":"Kevin J.","family":"Downes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Children's Hospital of Philadelphia  Philadelphia Pennsylvania USA"},{"name":"Department of Pediatrics Perelman School of Medicine, University of Pennsylvania  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17171"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae353"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.70098"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.07.013"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14714"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12363"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001595"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12030"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12179"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14220"},{"key":"e_1_2_10_12_1","unstructured":"\u201cPrescribing Information \u201dGenentech accessed June 5 2025 https:\/\/www.gene.com\/download\/pdf\/valcyte_prescribing.pdf."},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15142"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31825c4ba6"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000164512.99703.ad"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000925"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182463a19"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20103046.2006.00669.x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2431"},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","unstructured":"Y.Katsube K.Umemura Y.Urabe et\u00a0al. \u201cNUDT15Genetic Polymorphism as a Risk Factor for Early Neutropenia during Valganciclovir Prophylaxis in Lung Transplant Patients \u201dTransplant Infectious Disease https:\/\/doi.org\/10.1111\/tid.70108. forthcoming.","DOI":"10.1111\/tid.70108"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01855\u201018"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab195"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14107"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010077"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16138"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010025\u201001526\u2010z"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1851193"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.11.033"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piw008"},{"issue":"2","key":"e_1_2_10_31_1","article-title":"Low Systemic Ganciclovir Exposure and Preemptive Treatment Failure of cytomegalovirus Reactivation in a Transplanted Child","volume":"18","author":"Autmizguine J.","year":"2011","journal-title":"Journal of Population Therapeutics and Clinical Pharmacology"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01192\u201019"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70146","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tid.70146","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:19:24Z","timestamp":1770812364000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.70146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/tid.70146"],"URL":"https:\/\/doi.org\/10.1111\/tid.70146","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"2025-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70146"}}